From Nov 16, 2010 CC transcript: David Altreuer - -

New Post Public Reply Private Reply Replies (1) Message Board
Hike g2 #681

From Nov 16, 2010 CC transcript:

David Altreuer - - Private Investor

Yes, well, it is a nickel a share, you can't get much lower than that. So I guess it is attractive (multiple speakers) as long as you

think it is going to survive.

But my other concern is that when you have this many shares outstanding and there will be more as a result of the closing with

Epic, oftentimes companies entertain a reverse split to try to reduce the number of the float and increase the price of the stock.

Have you had any discussions along the lines of doing something like that?

Jerry Treppel - Elite Pharmaceuticals, Inc. - Chairman, CEO

I think it would be fair to say that we are well aware that the capitalization structure of the Company is an issue; okay? So let's

take care of that. It would also be fair to say that we do discuss what we can do about it. You know, I think we are all on the

same page here.

David Altreuer - - Private Investor

Okay. My experience of watching the market for the last 45 years tells me that reverse splits are initially the kiss of death for the

stock. It usually goes down dramatically after something like that.

But that is not saying that you don't have the substance to actually get it back up again, based on future sales and earnings and new products.

Jerry Treppel - Elite Pharmaceuticals, Inc. - Chairman, CEO

I have also as an analyst -- I have been around for 30 years, so it's not quite 45.

David Altreuer - - Private Investor

Okay.

Jerry Treppel - Elite Pharmaceuticals, Inc. - Chairman, CEO

Enough to have gray hairs. Generally what has tended to happen with reverse splits is the companies that do it are ones that

have issues, okay? In order for something like that to be successful it has to be done in conjunction with improving fundamentals

of a company.

David Altreuer - - Private Investor

Yes, exactly.

Jerry Treppel - Elite Pharmaceuticals, Inc. - Chairman, CEO

Elite is improving. We are very clearly improving. So that has to be considered.

Carter Ward - Elite Pharmaceuticals, Inc. - CFO

Yes, I think to use Jerry's analogy, the capitalization structure that we currently have is really a result of the issues of the past.

David Altreuer - - Private Investor

Okay.

Elite Pharmaceuticals Inc (ELTP) Stock Research Links

ELTP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 6

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 14

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 5

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 10

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Middlesex Water Company Welcomes Brian Hague as VP of Communications

Updated Category News Views 199

Brian Hague Joins Middlesex Water Company ISELIN, N.J. – Middlesex Water Company (NASDAQ: MSEX) is excited to announce the appointment of Brian Hague as the new Vice President of Communications and Corporate Affairs. In this significant role, Hague will concentrate on various aspects such as internal and external communications, crisis management, government affairs,...

Continue Reading
Colombia Stock Market Insights: A Boost in Key Sectors

Updated Category News Views 161

Colombia's Stock Market Performance On a recent trading day, Colombia's stock market showed positive movement, with various sectors contributing to this uptick. Investors observed gains particularly in the industrials, services, and agriculture sectors, which signifies a healthy market environment. The overall performance of the Colombian Stock Exchange indicates a...

Continue Reading
Nexxa.ai's Innovative AI Solutions Secure $4.4M Funding Boost

Updated Category News Views 275

Nexxa.ai Secures $4.4 Million in Funding to Revolutionize Heavy Industries Nexxa.ai, a trailblazing company specializing in AI solutions tailored for heavy industries, has recently concluded a significant pre-seed funding round, raising $4.4 million. This impressive financial backing was led by a16z speedrun, a notable venture capital firm, showcasing the company's rapid...

Continue Reading
Sharon Hague Takes Charge as President of Pearson's ELL Division

Updated Category News Views 239

Sharon Hague Takes Charge of Pearson's English Language Learning Division Pearson has announced an important leadership change that signals its continued commitment to education and language learning. The esteemed company has appointed Sharon Hague as the new President of its English Language Learning (ELL) division. This news comes as Pearson continues to broaden its...

Continue Reading
Empowering Gender Equity: The Launch of State Policy Action Lab

Updated Category News Views 195

Empowering Gender Equity with a New Tool The Institute for Women's Policy Research (IWPR) has unveiled its latest innovative initiative, the State Policy Action Lab (State PAL). This interactive platform consolidates over 100 gender equity data indicators, tracks nearly 500 state-level legislative bills, and offers actionable policy recommendations all in one...

Continue Reading